ITCC-066 LOXO 101
A Phase I/II Study of the Oral TRK Inhibitor LOXO 101 in Pediatric Patients with Advanced Solid or Primary Central Nervous System Tumors
Promotor Name : LOXO ONCOLOGY
Investigator Name : G. BISOGNIO
Trial registered on clinicaltrial.gov: NCT02637687